ORGANIC
LETTERS
2013
Vol. 15, No. 14
3702–3705
Synthesis and Properties of
20‑O,40‑C‑Ethyleneoxy Bridged
5‑Methyluridine
Yoshiyuki Hari,* Tomohiko Morikawa, Takashi Osawa, and Satoshi Obika*
Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka,
Suita 565-0871, Japan
hari@phs.osaka-u.ac.jp; obika@phs.osaka-u.ac.jp
Received June 4, 2013
ABSTRACT
20-O,40-C-Ethyleneoxy bridged 5-methyluridine (EoNA-T), possessing a seven-membered linkage and an anomeric 40-carbon, was synthesized and
introduced into oligonucleotides by using an automated DNA synthesizer. The EoNA-modified oligonucleotides significantly stabilized the
duplexes with single-stranded RNA and triplexes with double-stranded DNA relative to the natural oligonucleotide and oligonucleotides modified
by another seven-membered bridged 5-methyluridine, 20,40-BNACOC-T. In addition, EoNA-T showed excellent nuclease resistance.
Artificial nucleic acids that stabilize complexes with
target nucleic acids are useful materials for various nucleic
acid technologies such as gene therapy and genetic diag-
nosis. Among numerous analogs developed to date, nucleic
acids bridged between the 20- and 40-positions generally lead
to an increased affinity to single-stranded RNA (ssRNA) or
double-stranded DNA (dsDNA), or both.1ꢀ6 Moreover,
the bridged nucleic acids have increased resistance to nucle-
ase degradation when compared with a natural nucleic acid.
Thebridgesizebetweenthe20-and40-positions is considered
to crucially affect the binding affinity and nuclease resis-
tance. 20,40-Methylene-bridged nucleic acid (BNA/LNA)
with a five-membered bridge has outstanding high-binding
affinities to ssRNA and dsDNA, as well as improved
(1) Reviews: Kaur, H.; Babu, B. R.; Maiti, S. Chem. Rev. 2007, 107,
4672. Obika, S.; Rahman, S. M. A.; Fujisaka, A.; Kawada, Y.; Baba, T.;
Imanishi, T. Heterocycles 2010, 81, 1347.
(6) For other nucleic acids bridged between 20- and 40-positions, see: (a)
Kumar, R.; Singh, S. K.; Koshkin, A. A.; Rajwanshi, V. K.; Meldgaard, M.;
Wengel, J. Bioorg. Med. Chem. Lett. 1998, 8, 2219. (b) Singh, S. K.; Kumar,
R.; Wengel, J. J. Org. Chem. 1998, 63, 10035. (c) Varghese, O. P.; Barman, J.;
Pathmasiri, W.; Plashkevych, O.; Honcharenko, D.; Chattopadhyaya, J.
J. Am. Chem. Soc. 2006, 128, 15173. (d) Morita, K.; Hasegawa, C.; Kaneko,
M.; Tsutsumi, S.; Sone, J.; Ishikawa, T.; Imanishi, T.; Koizumi, M. Bioorg.
Med. Chem. Lett. 2002, 12, 73. (e) Rahman, S. M. A.; Seki, S.; Obika, S.;
Yoshikawa, H.; Miyashita, K.; Imanishi, T. J. Am. Chem. Soc. 2008, 130,
4886. (f) Seth, P. P.; Siwkowski, A.; Allerson, C. R.; Vasquez, G.; Lee, S.;
Prakash, T. P.; Wancewicz, E. V.; Witchell, D.; Swayze, E. E. J. Med. Chem.
2009, 52, 10. (g) Seth, P. P.; Vasquez, G.; Allerson, C. A.; Berdeja, A.; Gaus,
H.; Kinberger, G. A.; Prakash, T. P.; Migawa, M. T.; Bhat, B.; Swayze, E. E.
J. Org. Chem. 2010, 75, 1569. (h) Seth, P. P.; Allerson, C. R.; Berdeja, A.;
Siwkowski, A.; Pallan, P. S.; Gaus, H.; Prakash, T. P.; Watt, A. T.; Egli, M.;
Swayze, E. E. J. Am. Chem. Soc. 2010, 132, 14942. (i) Shrestha, A. R.; Hari,
Y.;Yahara, A.;Osawa, T.;Obika, S.J. Org. Chem. 2011, 76, 9891. (j) Yahara,
A.; Shrestha, A. R.; Yamamoto, T.; Hari, Y.; Osawa, T.; Yamaguchi, M.;
Nishida, M.; Kodama, T.; Obika, S. ChemBioChem 2012, 13, 2513. (k) Hari,
Y.; Osawa, T.; Kotobuki, Y.; Shrestha, A. R.; Yahara, A.; Obika, S. Bioorg.
Med. Chem. 2013, 21, 4405.
(2) (a) Obika, S.; Nanbu, D.; Hari, Y.; Morio, K.; In, Y.; Ishida, T.;
Imanishi, T. Tetrahedron Lett. 1997, 38, 8735. (b) Nielsen, P.; Wengel, J.
Chem. Commun. 1998, 455. (c) Koshkin, A. A.; Singh, S. K.; Nielsen, P.;
Rajwanshi, V. K.; Kumar, R.; Meldgaard, M.; Olsen, C. E.; Wengel, J.
Tetrahedron 1998, 54, 3607. (d) Obika, S.; Nanbu, D.; Hari, Y.; Andoh,
J.; Morio, K.; Doi, T.; Imanishi, T. Tetrahedron Lett. 1998, 39, 5401. (e)
Obika, S.; Hari, Y.; Sugimoto, T.; Sekiguchi, M.; Imanishi, T. Tetra-
hedron Lett. 2000, 41, 8923. (f) Obika, S.; Uneda, T.; Sugimoto, T.;
Nanbu, D.; Minami, T.; Doi, T.; Imanishi, T. Bioorg. Med. Chem. 2001,
9, 1001. (g) Torigoe, H.; Hari, Y.; Sekiguchi, M.; Obika, S.; Imanishi, T.
J. Biol. Chem. 2001, 276, 2354.
(3) Morita, K.; Takagi, M.; Hasegawa, C.; Kaneko, M.; Tsutsumi,
S.; Sone, J.; Ishikawa, T.; Imanishi, T.; Koizumi, M. Bioorg. Med. Chem.
2003, 11, 2211.
(4) (a) Hari, Y.; Obika, S.; Ohnishi, R.; Eguchi, K.; Osaki, T.; Ohishi,
H.; Imanishi, T. Bioorg. Med. Chem. 2006, 14, 1029. (b) Mitsuoka, Y.;
Kodama, T.; Ohnishi, R.; Hari, Y.; Imanishi, T.; Obika, S. Nucleic Acids
Res. 2009, 37, 1225.
(5) Nishida, M.; Baba, T.; Kodama, T.; Yahara, A.; Imanishi, T.;
Obika, S. Chem. Commun. 2010, 46, 5283.
r
10.1021/ol401566r
Published on Web 07/01/2013
2013 American Chemical Society